Life-threatening angioedema associated with ACE inhibitor treatment;Livstruende angioødem associeret med ACE-haemmer-behandling

Ugeskrift for Laeger

Volumn 165, Issue 10, 2003, Pages 1041-1042

  Olesen, Anne Lindhardt ^a,b   Tollund, Carsten ^b   Søndergaard, Inger ^b   Strøm, Jens Johan ^b  

^a Anæstesiol Afd Y Med Afd ^*  (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANTIHYPERTENSIVE AGENT; ENALAPRIL;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HYPERTENSION; MALE; RISK FACTOR; STRIDOR; UPPER RESPIRATORY TRACT OBSTRUCTION; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; RADIOGRAPHY;

ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ENALAPRIL; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037416781     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Slater EE, Merrill DD, Guess HA et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988;260: 967-70.
2. Jain M, Armstrong L, Hall J. Predisposition to and late onset of upper airway obstruction following angiotensin-converting enzyme inhibitor therapy. Chest 1992;102:8714.
3. Lapaostolle F, Borron SW, Bekka R et al. Lingual angioedema after perindopril use. Am J Cardiol 1992;81:523.
4. Thompson T, Frable MA. Drug-induced, life-threatening angioedema revisited. Laryngoscope 1993;103:10-2.
5. Yosuf S, Sleight P, Pouge J et al. Effects of an angiotensin-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342: 145-53.
6. American Society of Anesthesiologists. Practice guidelines for management of the difficult airway. Anesthesiology 1993;78:597-602.
7. Roberts JR, Wuertz RC. Clinical characteristics of angiotensin-converting enzyme inhibitor-induced angioedema. Ann Emerg Med 1991;20:555-8.
8. Crosher R. Intravenous tranexamic acid in the management of hereditary angioedema. Br J Oral Maxillofac Surg 1987;25:500-6.
9. Cosentino M, Leoni O, Michielotto D et al. Increased reporting of adverse reactions to ACE-inhibitors associated with limitations to drug reimbursement for Angiotensin-II receptor antagonists. Eur J Clin Pharmacol 2001; 57:509-12.